✦ LIBER ✦

Improving survival in inflammatory rheumatic diseases: a neglected goal?

✍ Scribed by Theodore Pincus; Allan Gibofsky; J. Timothy Harrington

Book ID: 107553844
Publisher: Springer
Year: 2006
Tongue: English
Weight: 68 KB
Volume: 8
Category: Article
ISSN: 1523-3774
DOI: 10.1007/s11926-006-0031-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interleukin-18: A novel cytokine in infl

Interleukin-18: A novel cytokine in inflammatory rheumatic disease

✍ Iain B. McInnes; J. Alastair Gracie; Foo Y. Liew 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 2 views

Colonoscopic surveillance improves survi

Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease

✍ Lutgens, M W M D; Oldenburg, B; Siersema, P D; van Bodegraven, A A; Dijkstra, G; 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 248 KB

Inflammatory responses to intradermal cr

Inflammatory responses to intradermal crystals in healthy volunteers and patients with rheumatic diseases

✍ P. A. Dieppe; M. Doherty; G. M. Papadimitriou 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 350 KB

Chlamydophila pneumoniaeantibodies in of

Chlamydophila pneumoniaeantibodies in office workers with and without inflammatory rheumatic diseases in a moisture-damaged building

✍ M. Seuri; M. Paldanius; M. Leinonen; M. Roponen; M.-R. Hirvonen; P. Saikku 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 156 KB

Reduction of stress—A new therapeutic go

Reduction of stress—A new therapeutic goal in the treatment of inflammatory bowel disease?

✍ Viktor E. Eysselein 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB 👁 2 views

Increased levels of serum pentraxin 3, a

Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease

✍ Ivana Hollan; Barbara Bottazzi; Ivan Cuccovillo; Øystein T. Førre; Knut Mikkelse 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 143 KB 👁 2 views

## Abstract ## Objective Pentraxin 3 (PTX3), a key component of innate immunity, is a strong marker of disease severity in coronary artery disease (CAD). The aim of this study was to compare levels of serum PTX3 in CAD patients with and without inflammatory rheumatic disease (IRD) and in healthy c